Tag: immune-related adverse events
Novel pH Mechanism may Enhance On-Target Effects with Reduced Off-Tumor Toxicity
The development of antibody-based immunotherapies has, compared with conventional therapeutic strategies patients, transformed the therapeutic landscape in melanoma, non-small cell lung cancer, bladder cancer,...